Back

The New Story of T1D: Autoimmune Science Meets Clinical Action: Rethinking T1D: An Autoimmune Disease We Can Now Modify

TARGET AUDIENCE This educational activity is intended for AAI membership and clinicians. PROGRAM OVERVIEW The goal of this activity is to bridge the gap between basic science and patient care by showing that T1D is an autoimmune disorder and how today’s targeted therapies provide better options for patients. LEARNING OBJECTIVES Upon completion of this activity, learners should be able to: 1. Describe the immunological mechanisms underlying T1D pathogenesis 2. Apply the staged model of T1D progression (Stages 1 3) to identify opportunities for early intervention 3. Integrate knowledge of poly-autoimmunity in T1D into comprehensive clinical management

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 1 credit

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Case-based learning
  • Credit · Up to 1 credit
  • Released
    Sep 30, 2026
  • Last day to claim credit
    Oct 1, 2027 12 months left